R
Richard B. Kim
Researcher at University of Western Ontario
Publications - 380
Citations - 33088
Richard B. Kim is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 89, co-authored 328 publications receiving 30436 citations. Previous affiliations of Richard B. Kim include London Health Sciences Centre & St. Jude Children's Research Hospital.
Papers
More filters
Journal ArticleDOI
Implementation of Pharmacogenomics- Where are we now?
S W Medwid,Richard B. Kim +1 more
TL;DR: The use of pharmacogenomics (PGx) in the clinical setting has been gaining momentum for several decades as discussed by the authors . Nevertheless, challenges have emerged in the broader clinical implementation of PGx, including a lack of diversity in PGx studies as well as general limitations that impact the broad adaption of PGX testing.
Journal Article
Sunscreens: An update
Mark Abramowicz,Gianna Zuccotti,Jean Marie Pflomm,Susan Morey,Eric J. Epstein,Philip D. Hansten,Jules Hirsch,David N. Juurlink,Richard B. Kim,Gerald L. Mandell,Hans Meinertz,Dan M. Roden,F. Estelle R. Simons,Neal H. Steigbigel,Donna Goodstein,Amy Faucard,Cynthia Macapagal Covey,Lauren K. Schwartz,Cheryl Brown,Liz Donohue,Susie Wong,Gene Carbona,Cristine Romatowski,Joanne F. Valentino,Yosef Wissner-Levy +24 more
Journal ArticleDOI
Human Epidermal Growth Factor Receptor 2-Targeting Approaches for Colorectal Cancer: Clinical Implications of Novel Treatments and Future Therapeutic Avenues.
C. Karan,Elaine Tan,H. Sarfraz,Todd C. Knepper,Christine M. Walko,Seth Felder,Richard B. Kim,Ibrahim Sahin +7 more
TL;DR: Recent clinical studies demonstrating the clinical benefits of each distinct therapeutic approach and their impacts on the current management of HER2-amplified mCRC are discussed and elaborate on novel therapeutic opportunities in this space that may further define the changing paradigm of Her2-targeted therapy for CRC.
Journal ArticleDOI
Duration of Grapefruit Juice Effect on Fexofenadine Interaction
TL;DR: In this paper, the authors proposed a new approach for drug development in clinical pharmacology and Therapeutics (2003) 73, P48-P48−P48; doi:
Journal Article
Sapropterin (Kuvan) for phenylketonuria
Mark Abramowicz,Gianna Zuccotti,Jean Marie Pflomm,Susan Morey,Eric J. Epstein,Philip D. Hansten,Jules Hirsch,David N. Juurlink,Richard B. Kim,Gerald L. Mandell,Hans Meinertz,Dan M. Roden,F. Estelle R. Simons,Neal H. Steigbigel,Donna Goodstein,Amy Faucard,Cynthia Macapagal Covey,Vanessa K. Dalton,Lauren K. Schwartz,Liz Donohue,Cheryl Brown,Susie Wong,Gene Carbona,Cristine Romatowski,Joanne F. Valentino,Yosef Wissner-Levy,Arthur Kallet,Harold Aaron +27 more